National Research Corp Class A NRC
About Quantitative Ratings
Morningstar Quantitative Ratings for Stocks are generated using an algorithm that compares companies that are not under analyst coverage to peer companies that do receive analyst-driven ratings. Companies with quantitative ratings are not formally covered by a Morningstar analyst, but are statistically matched to analyst-rated companies, allowing our models to calculate a quantitative moat, fair value, and uncertainty rating.
Is it the right time to buy, sell, or hold?
Start a free trial of Morningstar Investor to unlock exclusive ratings and continuous analyst coverage to help you decide if NRC is a good fit for your portfolio.
News
-
National Research Corporation to Broadcast Its First Quarter 2024 Conference Call Live on the Internet
-
Veteran Patient Experience Executive Jennifer Baron Joins NRC Health as Its First Chief Experience Officer
-
National Research Corporation Announces Fourth Quarter and Calendar Year 2023 Results
-
National Research Corporation to Broadcast Its Fourth Quarter and Year-end 2023 Conference Call Live on the Internet
-
NRC Health Expands Leadership Team to Accelerate Innovation, Meet Growing Demand for Insights and Solutions
-
Yuma Regional Medical Center Selects NRC Health as New Patient Experience Partner
Trading Information
- Previous Close Price
- $34.27
- Day Range
- $33.66–34.32
- 52-Week Range
- $32.08–47.25
- Bid/Ask
- $33.58 / $33.87
- Market Cap
- $809.38 Mil
- Volume/Avg
- 16,166 / 62,378
Key Statistics
- Price/Earnings (Normalized)
- 27.39
- Price/Sales
- 5.69
- Dividend Yield (Trailing)
- 1.40%
- Dividend Yield (Forward)
- 1.40%
- Total Yield
- 3.74%
Company Profile
National Research Corp is a provider of analytics and insights that facilitate measurement and improvement of the patient and employee experience while also increasing patient engagement and customer loyalty for healthcare providers, payers, and other healthcare organizations. Its portfolio of solutions represents a set of capabilities that individually and collectively provide value to clients. It operates in the United States and Canada, of which key revenue is derived from the United States.
- Sector
- Healthcare
- Industry
- Health Information Services
- Stock Style Box
- Small Core
- Total Number of Employees
- 435
- Website
- https://www.nrchealth.com
Valuation
|
Metric
|
NRC
|
|---|---|
Price/Earnings (Normalized) | 27.39 |
Price/Book Value | 16.94 |
Price/Sales | 5.69 |
Price/Cash Flow | 22.78 |
Price/Earnings
NRC
Financial Strength
|
Metric
|
NRC
|
|---|---|
Quick Ratio | 0.53 |
Current Ratio | 0.67 |
Interest Coverage | 46.41 |
Quick Ratio
NRC
Profitability
|
Metric
|
NRC
|
|---|---|
Return on Assets (Normalized) | 24.73% |
Return on Equity (Normalized) | 47.85% |
Return on Invested Capital (Normalized) | 34.87% |
Return on Assets
NRC
Health Information Services Industry Comparables
|
Ticker
|
Name
|
Morningstar Rating for Stocks
|
Capital Allocation
|
Economic Moat
|
Market Cap
|
|---|---|---|---|---|---|
GEHC
| GE HealthCare Technologies Inc Common Stock | — | Xlpbvb | $39.4 Bil | |
VEEV
| Veeva Systems Inc Class A | Lzqzrjnbj | $32.4 Bil | ||
SOLV
| Solventum Corp | — | Crcny | $11.0 Bil | |
MTHRF
| M3 Inc | — | Nbvdjqc | $8.3 Bil | |
MTHRY
| M3 Inc ADR | — | Jqkldgm | $8.2 Bil | |
PMCUF
| Pro Medicus Ltd | — | Hvqyyt | $7.2 Bil | |
HQY
| HealthEquity Inc | — | Gybhcrs | $6.8 Bil | |
RCM
| R1 RCM Inc | — | Drxfm | $5.0 Bil | |
DOCS
| Doximity Inc Class A | — | Yrvrcs | $4.5 Bil | |
EVH
| Evolent Health Inc Class A | — | Dfrt | $3.3 Bil |